chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He reports fever up to 40C, malaise, cough, R arm swelling that started 2 hours after receiving injection. Seen in Urgent Care on 8/12/18 with normal CBC, BMP. Arm pain/swelling  have improved over time but 6 days later he continued to have purulent cough and fatigue. CXR 8/16/18 showed RML pneumonia. Treated with doxycycline. I advised that pneumovax cannot cause pneumonia but promised him to report it.
11-05, STARTED WITH HEADACHE. BY 11-06 AM, PT HAD A RED RING AROUND THE TIP OF HIS NOSE- WHICH TOOK 2 DAYS TO GO AWAY.  STOMACH PAINS. NO FEVER, NO COUGH, NO SORE THROAT.
General malaise, headache, neck pain, chest pain, chest pressure, generalized polyarthralgias, DIP and PIP swelling, knee swelling, weakness, dizziness, mental fatigue and some confusion, fever
Rash started on 4/29 at 8pm the hives started to come up, i started taking benadryl over the counter but didnt seem to work, by Sunday May 2 my throat was feeling swollen so i went to the emergency room was given Benadryl through iv and steroids., and was sent home but monday morning 5/3 the hives got worse & felt like i couldnt breathe so return to emergency department was given Benadryl through iv and steroids and a epi pen was used then was transported through ambulance and admitted to hospital for further observation
fever and flu symptoms first couple days. Then, aa few days later ears ringing, and about a week after second vaccine, stiff neck, sore arm (not the one of the shot) inflammation in arm, neck, shoulder and intercostal muscle in back, headaches. Been continuing ever since. It has been over two months. Still have the ears ringing.
Information has been received from a physician concerning a 24 year old female who was intramuscularly vaccinated with her second dose of Gardasil (lot # 658560/1062U). Concomitant therapy included PERCOCET. About a month after the vaccine was administered, the patient sought unspecified medical treatment via an office visit for a painful lump at the injection site. The patient did not have any adverse reactions to the first dose. Additional information has been requested.
About 5 minutes post vaccine administration patient called out staff members name and slowly lowered herself from the chair to floor. Patient laid on the floor reporting a feeling of lightheadedness, dizzy, and had tingling in her bilateral hands. RN assessed patient. Patient vitals were taken, ice pack, water and crackers provided to patient. Patient denied any other symptoms at that time.  After a few minutes patient was able to position herself to an upright position and reported feeling better, denying any symptoms at that time. Patient was monitored for an additional 30 minutes and left the clinic ambulatory without any concerns.
WORSENING RASH/HIVES ON LOWER BACK AND HIP AREAS; HEADACHE; FEVERISH; COLD SWEATS; This spontaneous report received from a patient concerned a 37 year old female. The patient's weight was 250 pounds, and height was 175 centimeters. The patient's concurrent conditions included non alcohol user, and non smoker, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. the patient had no known allergies and no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 2021, treatment medications included: ibuprofen. On 31-MAR-2021, the subject experienced cold sweats. On 31-MAR-2021, the subject experienced headache. On 31-MAR-2021, the subject experienced feverish. Laboratory data included: Body temperature (NR: not provided) Normal. On 20-APR-2021, the subject experienced worsening rash/hives on lower back and hip areas. On 22-APR-2021, treatment medications included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from cold sweats, headache, and feverish on 04-APR-2021, and had not recovered from worsening rash/hives on lower back and hip areas. This report was non-serious.; Sender's Comments: V0:Medical assessment comment not required as per standard operating procedure as the case is assessed as Non-serious.
BREAKTHROUGH CHICKENPOX FEBRUARY 2009.  RECEIVED VARIVAX 8/1/2003 AND PROQUAD 8/18/2006.
Swelling at the injection site / has not resolved; This case was reported by a other health professional via call center representative and described the occurrence of injection site swelling in a 4-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA438A, expiry date 31st October 2021) for prophylaxis.   On 2nd February 2021, the patient received Menveo. In February 2021, less than a week after receiving Menveo, the patient experienced injection site swelling. On an unknown date, the outcome of the injection site swelling was not recovered/not resolved.   It was unknown if the reporter considered the injection site swelling to be related to Menveo.  Additional details were provided as follows: The patient received Menveo and had only adverse event that was seen was some swelling at the injection site.  The swelling had not resolved and the parent of the child had not reported any other adverse event. The reporter did not consent to follow up. This case linked with US2021030538, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021030538:Same reporter.
45 min after receiving flu imm - at hospital flu imm clinic, face became flushed, lips felt fuzzy, felt nauseated and dizzy with mild SOB and hyperventilation.
Information has been received from a physician concerning a 26 week old female who on 25-MAY-2007 and 08-AUG-2007 was vaccinated PO with her first and second 2.0 ml doses of Rotateq (lot# "12337," 656393/0240U).  On 21-SEP-2007 the patient was seen in the physician's office since the patient experienced vomiting, crying and loose stools.  The patient did not have bloody stools.  The patient was admitted to a hospital that same day and was diagnosed with intussusception.  The patient was hospitalized for 3 days.  A barium enema resolved the intussusception.  The patient was discharged from the hospital on 23-SEP-2007.  On 24-SEP-2007 the patient was seen in the physician's office and the physician stated the patient had been vomiting, but with no dehydration.  The patient had a bowel movement with no blood in the stools.  Therapy with Rotateq was discontinued on 08-AUG-2007.  The physician stated the patient was recovering.  There was no product quality complaint.  Additional information has been requested.8/4/08-records received for DOS 9/21-9/23/07-DC DX: Intussusception. Presented to ED with C/O vomiting and loose bowel movement times 1-2 days. Crying, irritable.
Fever - 100.7; Aches; This case was reported by a consumer via call center representative and described the occurrence of fever in a 75-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th February 2020, the patient received the 2nd dose of Shingrix. In February 2020, less than a week after receiving Shingrix, the patient experienced fever and pain. On an unknown date, the outcome of the fever and pain were unknown.   It was unknown if the reporter considered the fever and pain to be related to Shingrix.  Additional details were provided as follows: The patient receivde dose of Shingrix vaccine and had fever and aches.
It was menstrual cycle related. I had very intense cramping and heavy bleeding with clotting. I am on birth control so my cycles are usually regular and normal. It lasted for about 3-4 months after the vaccine.
Shoulder locked up. Movement became extremely painful and restricted. I was unable to lift my left arm above shoulder-level. Rotation limited to ~20 degrees off body center. I received acupuncture, followed by several weeks of physical therapy to loosen the joint.
I got a headache a few hours after the vaccine.  I took tylenol and drank alot of water It did not go away I have taken all different types of pain relievers.  tylenol advil excedriene   I still have the headache two month later
A non-contactable physician reported for a patient of unspecified age and gender received BNT162B2 (Solution for injection), subcutaneous on an unspecified date as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received vaccine via subcutaneous. It was reported that a person who received the Pfizer covid vaccine last week and said they got it subcutaneous (sub Q) and it bubbled up.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report as received from a pharmacist, via a company representative, refers to a male patient of unknown age. The patient had a prior history of shingles before receiving ZOSTAVAX. No information on his concurrent conditions or concomitant drugs was provided. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX, 1 injection, site and route of administration, lot#, expiration date unknown. It was reported that since receiving ZOSTAVAX the patient experienced two outbreaks of shingles (dates unspecified). The patient did not seek medical attention. Therapy with ZOSTAVAX was reportedly continued. The outcome of two outbreaks of shingles was unknown. Relatedness between use of ZOSTAVAX and the adverse event was unknown. Additional information has been requested.
After having the Moderna Booster, large red bump developed on left arm within first 6 hours and stayed on the arm for 5 days and after 10 days of booster I pretty much started having a severe rash/hives/itchiness all over the body (throughout my arms, back, neck, chest, stomach, inside the palms, fingers, thighs, shins, feet, and under the feet). From the 18th I cant stand the look of it. Have seek the help of urgent care and primary care physician, and I'm on steroids now. This rash has taken my peace of mind and its impacting my job and sleepless nights.
No side effects initially other than mild injection site swelling,   One week later,   the injection site has  become swollen severely to a 8cm x 6 cm large red, warm to touch area that is itching , with mild hive like bumps in the reddened area .  Mildly  painful
Asthma; cough; This is a spontaneous report from a contactable consumer. A currently 73-year-old received the vaccine at 67 or 68 years old, pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein (PREVNAR 13, lot number: unknown), via an unspecified route of administration in 2013 at single dose for immunization. The patient's medical history and concomitant medications were not reported. The reported stated that back in 2013, his brother took the vaccine and within a year and half after he took it he developed asthma, also stated that neither one of them smoke or drink alcohol, seems there possibly seems to be a connection between the DNA. The reported added that his brother is now he is on maximum steroid for the treatment of it, has a cough that is just terrible, pulmonary specialist cannot seem to figure it out. The outcome of events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
On December 29th, 2020. My father had the vaccination shot from Pfizer. My father's first symptoms of the vaccine were fatigue, dizziness, loss of balance. My father didn't even remember how he drove home and how he managed to open the door. When he came inside the house. The first thing he did was lay on the couch. On December 29th. 2020 from that day forward my father did not. Go back to work to hospital.
Infection site tender as expected.  Ibuprofen was needed for pain.  The next morning 12/10/2021 early woke up to severe flu-like symptoms.  Same symptoms as the first shot.  Temperature 104 full body aches, headache, nausea unable to function and do normal activities.  The doctor said that this is a normal reaction and that if the symptoms don't get better in a few days to call back.  She was feeling a little better after a week of the initial day of the shot.   Advised not to get the booster because of the severity of the two vaccines already administered.
Woke up in AM after injection with blurred vision, left eye greater than right. Attempted to use lubricating drops without resolution. No other interventions. Symptoms resolved day 2 after vaccination.
The pt experienced skin redness, chills, scratching, raise wheals on elbows.
I had soreness; started with itching, redness and swelling at site of immunization.; started with itching, redness and swelling at site of immunization./5.0 cm area of redness and induration; 5.0 cm area of redness and induration at site; started with itching, redness and swelling at site of immunization.; This is a spontaneous report from a contactable physician (patient herself). A 42-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ek5730, expiry date not reported), via an unspecified route of administration on the left arm on 17Dec2020 10:15 at single dose for COVID-19 immunisation. Medical history included food allergy, oral allergy, no anaphylaxis. Concomitant medications were not reported. On 26Dec2020 18:00, the patient started with itching, redness and swelling at site of immunization. Patient also had a 5.0 cm area of redness and induration at site. Patient also had soreness on an unspecified date but no other reaction. No therapeutic measure was taken as a result of the events. Clinical outcome of pain was unknown while for the other events was not recovered.  Follow-up attempts are not possible. No further information is expected.
A few days ago, I began to feel pain in my left arm where I had the injection, and it has swelled up and turned red. So far I have not treated this side effect.
onset of rash 4/10/99 for 3 days; about 51 pox
Left lymph node was softball- sized this time; Aches; Fever; Headache; Sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old female patient received BNT162b2 (BNT162B2), on 07Mar2022 at 17:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 52 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "COVID-19", start date: Mar2020 (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Lot no: EW0175), for COVID-19 immunization, reaction(s): "So Sick"; Bnt162b2 (Dose 2, Lot no: EW0186), for COVID-19 immunization, reaction(s): "So Sick". The following information was reported: PAIN (non-serious) with onset 2022, outcome "recovered" (2022), described as "Aches"; PYREXIA (non-serious) with onset 2022, outcome "recovered" (2022), described as "Fever"; HEADACHE (non-serious) with onset 2022, outcome "recovered" (2022); LYMPHADENOPATHY (non-serious) with onset 2022, outcome "recovered" (2022), described as "Left lymph node was softball- sized this time"; ILLNESS (non-serious) with onset 2022, outcome "recovered" (2022), described as "Sick".  Additional Information: Patient was submitting this because patient had to get a third (booster) shot for work. Because patient was so sick with the first 2 shots (6 days each time), patient didn't want to be boosted but had to for work plus travel. Once again had a bad reaction to the 3rd dose. Patient stated there really needs to be a smaller dose for people like patient who had COVID plus react to the vaccines.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Nausea post vaccine 10:30 AM.  School, home ill 4 PM. Gradual increasing. took ibuprofen 200 mg 2-3 per 4-5 hours with some relief. Then stomach ache. Slight cough. Used ice. Office visit for severe headache. Appeared highly irritable and in pain.  Moderately cooperative, appropriate for teenager in severe pain. 0-10 pain choice self rated "58".  C/o headache, L arm pain.Demerol 20 mg IV given with some significant relief. Pain level 3-4-5/10. Home.  Full recovery 4-5 days.
his arm got numb; shaking; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 53 year-old male patient received bnt162b2 (COMIRNATY), administered in arm right, administration date Feb2021 (Batch/Lot number: unknown) at the age of 52 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (dose 1), administration date: Feb2021, when the patient was 52 years old, for COVID-19 immunization. The following information was reported: HYPOAESTHESIA (non-serious) with onset Feb2021, outcome "recovered" (Feb2021), described as "his arm got numb"; TREMOR (non-serious) with onset Feb2021, outcome "recovered" (Feb2021), described as "shaking".  Additional Context: Warm transfer (name) with Pfizer states the caller is a patient, caller states he was 52 at time of the administration of Pfizer Covid vaccines, when he got his vaccines reports arm got numb and started shaking, also heard that some people who had numbness got nerve damage. Clarifies that it happened after the second shot took all day to recover, right arm, completely recovered. States that he had spoken to people who know people that have had permanent nerve damage after the vaccines. No further information provided. Recovered completely, states he is unsure of the exact date he got the vaccine, states it happened all in about 10 minutes immediately after the second dose. Caller states the first dose didn't do anything, just had issues after the second dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a medical assistant referring to 3 unspecified patients of unknown age. On an unknown date, the patient was vaccinated with improperly stored doses of VARIVAX lot # N012488, expiration date 20-APR-2019,  for prophylaxis. Concomitant therapies included sterile diluent(DILUENT MRK). No adverse events. The vaccines were exposured to 6.2 degrees Celsius.; Sender's Comments: US-009507513-1708USA008324:
Pfizer vaccination was administered intramuscularly by immunizing technician.  Within minutes of administration the patient fainted.  He then came to immediately and fainted a second time.  He came to and fainted a third time.  Each time he fainted he was also shaking in an unusual manner.  Because it happened in the manner it did, we contacted EMS.
Pt has a history of COPD and lung cancer. Pt was admitted for afib and RVR and was found to be COVID positive.
Same day post vax, the pt developed hives, lightheadedness, and chest pain. Sent to the ER.
Moderate pain at injection site. Redness in round pattern of 1.5 inch radius around the injection site.
Approx 3PM 12FEB92 pt had temp & exp onset of shaking, & chills; pts grandma stated  pt began making funny noises & became very lethargic, making multiple attemps to fall asleep; taken to ER t104.8; adm to hosp with temp & neck rigidity;
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 25-MAR-2014, the patient was inoculated at a pharmacy with the ZOSTAVAX vaccine as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. In 2016, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Systemic: Seizure-Mild, Additional Details: Called patient and it seems that she had another seizure episode in the ambulance. She's doing okay.
DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C.
Following the vaccine her arm was sore to the touch for a couple of days.  Then around the 15th in the morning she got up and noticed a small bump on her arm, and it started to spread.  It looks like a reaction from a TB positive shot.  Yesterday it started itching, 2/25/21, started to put some cortisone cream on it, and it has turned redder since then.  She continues to have the itching.  The area has spread more on her arm, but nothing else has changed.  She is going to call her doctor today as she is still having the symptoms.
Left arm swollen, 33 cm around, parents applied heat which seemed to make it worse, had some nausea. Right arm was 29.5 cm, so Left arm was significantly more swollen.
This spontaneous report was received from a registered pharmacist refers to a patient of unknown age who on an unknown date, was vaccinated with a dose of ZOSTAVAX (dose, route and lot number not reported). No other co-suspects were reported. No concomitant medications were reported. It was reported that on an unknown date, the patient developed bumps on both arms after receiving ZOSTAVAX. This was not a rash. No treatment information was reported. This resolved soon afterwards on an unspecified date. It was unspecified if the patient sought medical attention. The relatedness for patient developed bumps on both arms was unknown for ZOSTAVAX. This is one of several reports from the same source. Additional information has been requested.
This is a spontaneous report from a contactable physician via a sales representative. A 18-year-old female patient of an unspecified ethnicity received TRUMENBA at 0.5 ml single and MENACTRA at 1 dosage form single, both via an unspecified route of administration on an unspecified date at the same time/visit. Medical history and concomitant medications were not reported. After the vaccination, the patient had to go to the emergency room with a fever and her throat was closing up, she could not breathe, so, it was like an anaphylactic response. The outcome of the events was unknown. Follow-up (05Feb2016): Follow-up attempts completed. No further information expected.
Large rash around injection site .  Itchy  swollen.  Currently using cortisone
This spontaneous report was received from a nurse refers to an unknown number of patients of unknown age and gender. No concurrent condition or medical history were reported. On an unknown date the patients were vaccinated with improperly stored (temp. 12 degree Celsius, time 6 hours) ROTATEQ (lot # L010126, xp. 22-JAN-2017, dose and route of administration not provided). No concomitant therapy was reported. No adverse effects were reported. The outcome of the event was unknown. No product quality issue was involved. This is one of the several reports from the same reporter link. Additional information is not expected since the reporter did not wish further contact.